The impact of anti-thymocyte globulin on the outcomes of Patients with AML with or without measurable residual disease at the time of allogeneic hematopoietic cell transplantation

Arnon Nagler; Bhagirathbhai Dholaria; Myriam Labopin; Gerard Socie; Anne Huynh; Maija Itälä-Remes; Eric Deconinck; Ibrahim Yakoub-Agha; Jean-Yves Cahn; Jean-Henri Bourhis; Helene Labussiere-Wallet; Sylvain Chantepie; Jordi Esteve; Bipin Savani; Mohamad Mohty

doi:10.1038/s41375-019-0631-5

The impact of anti-thymocyte globulin on the outcomes of Patients with AML with or without measurable residual disease at the time of allogeneic hematopoietic cell transplantation

Arnon Nagler, Bhagirathbhai Dholaria, Myriam Labopin, Gerard Socie, Anne Huynh, Maija Itälä-Remes, Eric Deconinck, Ibrahim Yakoub-Agha, Jean-Yves Cahn, Jean-Henri Bourhis, Helene Labussiere-Wallet, Sylvain Chantepie, Jordi Esteve, Bipin Savani, Mohamad Mohty

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Originalspråk	engelska
Tidskrift	Leukemia
Volym	34
Nummer	4
Sidor (från-till)	1144-1153
Antal sidor	10
ISSN	0887-6924
DOI	https://doi.org/10.1038/s41375-019-0631-5
Status	Publicerad - apr. 2020
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Vetenskapsgrenar

3122 Cancersjukdomar

Åtkomst av dokument

10.1038/s41375-019-0631-5

Citera det här

Nagler, A., Dholaria, B., Labopin, M., Socie, G., Huynh, A., Itälä-Remes, M., Deconinck, E., Yakoub-Agha, I., Cahn, J.-Y., Bourhis, J.-H., Labussiere-Wallet, H., Chantepie, S., Esteve, J., Savani, B., & Mohty, M. (2020). The impact of anti-thymocyte globulin on the outcomes of Patients with AML with or without measurable residual disease at the time of allogeneic hematopoietic cell transplantation. Leukemia, 34(4), 1144-1153. https://doi.org/10.1038/s41375-019-0631-5

@article{27979e5b5bc241daa7d289b1d3b6b76a,

title = "The impact of anti-thymocyte globulin on the outcomes of Patients with AML with or without measurable residual disease at the time of allogeneic hematopoietic cell transplantation",

keywords = "MATCHED UNRELATED DONORS, ACUTE MYELOID-LEUKEMIA, CHRONIC GRAFT, HOST-DISEASE, REDUCED-INTENSITY, FREE SURVIVAL, OPEN-LABEL, STANDARD, GVHD, PROPHYLAXIS, 3122 Cancers",

author = "Arnon Nagler and Bhagirathbhai Dholaria and Myriam Labopin and Gerard Socie and Anne Huynh and Maija It{\"a}l{\"a}-Remes and Eric Deconinck and Ibrahim Yakoub-Agha and Jean-Yves Cahn and Jean-Henri Bourhis and Helene Labussiere-Wallet and Sylvain Chantepie and Jordi Esteve and Bipin Savani and Mohamad Mohty",

year = "2020",

month = apr,

doi = "10.1038/s41375-019-0631-5",

language = "English",

volume = "34",

pages = "1144--1153",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "4",

}

Nagler, A, Dholaria, B, Labopin, M, Socie, G, Huynh, A, Itälä-Remes, M, Deconinck, E, Yakoub-Agha, I, Cahn, J-Y, Bourhis, J-H, Labussiere-Wallet, H, Chantepie, S, Esteve, J, Savani, B & Mohty, M 2020, 'The impact of anti-thymocyte globulin on the outcomes of Patients with AML with or without measurable residual disease at the time of allogeneic hematopoietic cell transplantation', Leukemia, vol. 34, nr. 4, s. 1144-1153. https://doi.org/10.1038/s41375-019-0631-5

The impact of anti-thymocyte globulin on the outcomes of Patients with AML with or without measurable residual disease at the time of allogeneic hematopoietic cell transplantation. / Nagler, Arnon; Dholaria, Bhagirathbhai; Labopin, Myriam et al.
I: Leukemia, Vol. 34, Nr. 4, 04.2020, s. 1144-1153.

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

TY - JOUR

T1 - The impact of anti-thymocyte globulin on the outcomes of Patients with AML with or without measurable residual disease at the time of allogeneic hematopoietic cell transplantation

AU - Nagler, Arnon

AU - Dholaria, Bhagirathbhai

AU - Labopin, Myriam

AU - Socie, Gerard

AU - Huynh, Anne

AU - Itälä-Remes, Maija

AU - Deconinck, Eric

AU - Yakoub-Agha, Ibrahim

AU - Cahn, Jean-Yves

AU - Bourhis, Jean-Henri

AU - Labussiere-Wallet, Helene

AU - Chantepie, Sylvain

AU - Esteve, Jordi

AU - Savani, Bipin

AU - Mohty, Mohamad

PY - 2020/4

Y1 - 2020/4

KW - MATCHED UNRELATED DONORS

KW - ACUTE MYELOID-LEUKEMIA

KW - CHRONIC GRAFT

KW - HOST-DISEASE

KW - REDUCED-INTENSITY

KW - FREE SURVIVAL

KW - OPEN-LABEL

KW - STANDARD

KW - GVHD

KW - PROPHYLAXIS

KW - 3122 Cancers

U2 - 10.1038/s41375-019-0631-5

DO - 10.1038/s41375-019-0631-5

M3 - Article

SN - 0887-6924

VL - 34

SP - 1144

EP - 1153

JO - Leukemia

JF - Leukemia

IS - 4

ER -